Leaders at the Fred Hutch Cancer Center said the Trump administration's proposed NIH funding cuts would be "chilling, ...

Last year was one of the most productive in the history of the Allen Institute for Artificial Intelligence (Ai2). Next up: translating all that work into real-world solutions.

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to ...

If you believe that biomedical research is good for our state and our country, contact your elected representatives and ask them to reverse the NIH cuts. Talk to your friends and family. Let them know ...

Fred Hutch’s Phase 2 study among blood cancer patients is a “gamechanger” in preventing graft-versus-host disease after ...

Seattle's Fred Hutch Cancer Center to invest $13.5 million in cybersecurity upgrades following 2023 data breach settlement. Class members may receive up to $5K.

Neoadjuvant chemoimmunotherapy for muscle-invasive bladder cancer (MIBC) followed by risk-adapted therapy led to high rates ...

Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...

Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.

A new blood test has the potential to identify a hard-to-predict but sometimes deadly pregnancy complication weeks before it would normally be found, leading to early treatment and possibly prevention ...

The remains of a 50,000-year-old baby mammoth uncovered by melting permafrost in Russia’s Siberia have been unveiled to the public. Nicknamed Yana, the female mammoth weighs more than 100kg and is ...

A phase 2 study evaluated the use of ruxolitinib plus standard GVHD prophylaxis in patients with myelofibrosis undergoing ...